Latest Options News

Octava Minerals has successfully completed the initial phase of its $1.5 million capital raise, positioning the company to advance exploration and due diligence at its promising Federation Copper-Zinc-Silver Project.

Prodigy Gold has successfully raised over $7 million through a combined entitlement offer and placement, with Plutus Prospecting increasing its voting power to 19.9%. The funds will fuel exploration and development in the prolific Tanami Gold Province.

Austral Gold’s Q2 2025 report reveals a production decline at its flagship Guanaco Mine alongside rising costs, while refurbishment at its Casposo Plant advances on schedule for a second-half restart.

Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.

Dateline Resources advances its Colosseum Gold-REE Project with a robust feasibility study, expanded exploration, and strong US government support, positioning itself as a key player in critical minerals.

Transurban Group has updated its dividend notification to include the Dividend Reinvestment Plan (DRP) price for its ordinary dividend of 33 cents per stapled security, partially franked at just 0.0518%.

Syrah Resources has launched a A$70 million equity raising and secured a two-year forbearance on its US Department of Energy loan, bolstering its cash position and operational flexibility amid ongoing challenges.

Otto Energy has completed a $38.4 million capital return while maintaining steady oil production despite a dip in gas output. The company also announced the resignation of its Acting CEO, signaling a period of transition.

Titan Minerals reports strong drilling results at its Dynasty Gold and Linderos Copper projects, confirming significant mineralisation extensions and advancing joint venture milestones.

Syntara Limited reports encouraging Phase 2 data for its lead drug amsulostat in myelofibrosis, secures FDA Fast Track status, and expands clinical programs into myelodysplastic syndrome and keloid scars.

Beonic Limited reported a landmark $15.2 million contract win in North Africa alongside strong Q4 FY25 EBITDA profitability and positive cash flow, signaling robust operational momentum heading into FY26.

CurveBeam AI reported a solid 18% increase in purchase orders for FY25, alongside record cash receipts and positive operational cash flow in Q4. The company is also advancing a significant vendor financing facility to support growth in key markets.